Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6195)
  2. Meeting Abstract (6166)
  3. Review (401)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (160)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11094)
  2. Hematologic Malignancies, Division of (10645)
  3. GSK Faculty (5449)
  4. Adult Leukemia (3723)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (946)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (317)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (268)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1669)
  3. Nature Publishing Group (1118)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hsp90 at the hub of metabolic homeostasis in malignant B cells
    Meeting Abstract

    Calvo-Vidal, N.; Patel, J.; Krumsiek, J.; Dupont, T.; Goldstein, R.; Yang, S. N.; Melnick, A.; Chiosis, G.; Cerchietti, L.
    Blood (2014)

    Fulltext@MSK | Save
  • Somatic mutations in TET2, but not SF3B1, are prevalent during normal aging hematopoiesis in human
    Meeting Abstract

    Buscarlet, M.; Busque, L.; Lepine, G.; Levine, R. L.
    Blood (2014)

    Fulltext@MSK | Save
  • Preclinical efficacy of MEK inhibition in NRAS mutant acute myeloid leukemia
    Meeting Abstract

    Burgess, M. R.; Hwang, E.; Firestone, A. J.; Huang, T. N.; Xu, J.; Zuber, J.; Bohin, N.; Wen, T.; Kogan, S. C.; Haigis, K. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • BL-8040, a peptidic CXCR4 antagonist, induces leukemia cell death and specific leukemia cell mobilization in relapsed/refractory acute myeloid leukemia patients in an ongoing phase IIA clinical trial
    Meeting Abstract

    Borthakur, G.; Nagler, A.; Ofran, Y.; Rowe, J. M.; Altman, J. K.; Frankfurt, O.; Tallman, M. S.; Avivi, I.; Peled, A.; Pereg, Y.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Autoimmune hemolysis & immune thrombocytopenic purpura after cord blood transplantation (CBT) may be life-threatening & warrants early therapy with rituximab
    Meeting Abstract

    Bhatt, V.; Shune, L.; Lauer, E. J.; Lubin, M. N.; Devlin, S. M.; Scaradavou, A.; Kernan, N. A.; Giralt, S.; Parameswaran, R.; Perales, M. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Analysis of VDT-PACE utilization in multiple myeloma patients treated at MSKCC for relapsed disease or cytoreduction and stem cell mobilization after initial induction therapy
    Meeting Abstract

    Beyer, K.; Rosner, S.; Woo, K. M.; Devlin, S. M.; Landau, H.; Hassoun, H.; Lendvai, N.; Chung, D. J.; Adel, N. G.; Puto, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Identification of actionable genomic alterations across different lymphoma histologies using a comprehensive next generation genomic sequencing clinical assay
    Meeting Abstract

    Batlevi, C.; Moskowitz, C. H.; Zelenetz, A. D.; Horwitz, S. M.; Palomba, L.; Gerecitano, J. F.; Copeland, A. R.; Hamlin, P.; Matasar, M. J.; Sauter, C. S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Telomere length recovery strongly predicts overall survival in acute promyelocytic leukemia
    Meeting Abstract

    Baljevic, M.; Dumitriu, B.; Lee, J. W.; Paietta, E.; Racevskis, J.; Chen, C.; Stein, E. M.; Gallagher, R. E.; Rowe, J. M.; Appelbaum, F. R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Nivolumab in patients with relapsed or refractory Hodgkin lymphoma - Preliminary safety, efficacy and biomarker results of a phase I study
    Meeting Abstract

    Armand, P.; Ansell, S. M.; Lesokhin, A. M.; Halwani, A.; Millenson, M. M.; Schuster, S. J.; Timmerman, J.; Borrello, I.; Gutierrez, M.; Scott, E. C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Multiparameter phosphoprofiling of the B-cell receptor pathway in Waldenstrom's macroglobulinemia
    Meeting Abstract

    Argyropoulos, K. V.; Ziegler, C. G. K.; Altan-Bonnet, G.; Dogan, A.; van den Brink, M. R. M.; Palomba, M. L.
    Blood (2014)

    Fulltext@MSK | Save